(Q44136140)

English

Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes

scientific article published on 2 February 2013

Statements

Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes (English)
2 February 2013
1337-1344

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit